Helius Medical Technologies, Inc.

Helius Medical Technologies, Inc.

HSM.TO
Helius Medical Technologies, Inc.CA flagToronto Stock Exchange
18.35
CAD
-0.32
(-1.71%)
-10.60EPS
-1.73P/E
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
Dane Carl Andreeff
Full Time Employees
19
Sector
Healthcare
Industry
Medical - Devices
Address
642 Newtown Yardley Road Newtown PA United States of America
IPO Date
Apr 18, 2016
Similar Companies
Business
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.